Kastenmayer Robin J, Moore Rashida M, Bright Allison L, Torres-Cruz Rafael, Elkins William R
Comparative Medicine Branch, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, USA.
J Am Assoc Lab Anim Sci. 2012 May;51(3):333-8.
In the interval between the publication of the seventh and eighth editions of the Guide for the Care and Use of Laboratory Animals (Guide), much has changed with regard to the regulation and funding of highly pathogenic biologic agents and toxins (Select Agents). Funding of research involving highly pathogenic agents has increased dramatically during this time, thus increasing the demand for facilities capable of supporting this work. The eighth edition of the Guide briefly mentions Select Agents and provides a limited set of references. Here we provide some background information regarding the relevant laws and regulations, as well as an overview of the programmatic requirements pertaining to the use of Select Agents, with a focus on use in animals.
在《实验动物饲养与使用指南》(《指南》)第七版和第八版出版的间隔期间,高致病性生物制剂和毒素(选择制剂)的监管和资金方面发生了很大变化。在此期间,涉及高致病性制剂的研究资金大幅增加,从而增加了对能够支持这项工作的设施的需求。《指南》第八版简要提及了选择制剂并提供了有限的参考文献。在此,我们提供一些有关相关法律法规的背景信息,以及关于使用选择制剂的程序要求概述,重点是在动物中的使用。